Skip to main content

Table 1 Patient characteristics between the training and testing dataset

From: A non-lab nomogram of survival prediction in home hospice care patients with gastrointestinal cancer

Patient characteristic

Training set

Testing set

P

Patient characteristic

Training set

Testing set

P

No. of patients

1214

404

 

Surgery (%)

  

0.792

Survival time (median [IQR]), days

35.00 [17.00, 66.00]

34.00 [18.00, 68.00]

0.844

N

680 (56.0)

230 (56.9)

 

Sex (%)

  

0.037

Y

534 (44.0)

174 (43.1)

 

 Female

378 (31.1)

103 (25.5)

 

Chemotherapy (%)

  

0.946

 Male

836 (68.9)

301 (74.5)

 

N

777 (64.0)

260 (64.4)

 

Age (%)

  

0.103

Y

437 (36.0)

144 (35.6)

 

 < 60 years

527 (43.4)

156 (38.6)

 

Radiotherapy (%)

  

0.038

 ≥ 60 years

687 (56.6)

248 (61.4)

 

N

1085 (89.4)

345 (85.4)

 

Area of residence (%)

  

0.083

Y

129 (10.6)

59 (14.6)

 

 Rural

379 (31.2)

107 (26.5)

 

Duration of pain (%)

  

0.247

 Urban

835 (68.8)

297 (73.5)

 

< 1 month

259 (21.3)

102 (25.2)

 

Education (%)

  

0.863

1–6 months

831 (68.5)

260 (64.4)

 

 Illiteracy

163 (13.4)

61 (15.1)

 

6–12 months

99 (8.2)

30 (7.4)

 

 Primary school

589 (48.5)

199 (49.3)

 

> 12 months

25 (2.1)

12 (3.0)

 

 Middle school

292 (24.1)

89 (22.0)

 

Previous analgesic treatment (%)

  

0.642

 High school

133 (11.0)

42 (10.4)

 

None

349 (28.7)

116 (28.7)

 

 High school above

37 (3.0)

13 (3.2)

 

NSAIDs

123 (10.1)

50 (12.4)

 

Awareness of the disease (%)

  

0.121

Weak Opioids

373 (30.7)

119 (29.5)

 

 Full understanding

675 (55.6)

212 (52.5)

 

Strong Opioids

369 (30.4)

119 (29.5)

 

 Partial understanding

191 (15.7)

55 (13.6)

 

Effect (%)

  

0.995

 Complete ignorance

348 (28.7)

137 (33.9)

 

None

280 (23.1)

94 (23.3)

 

Metastasis (%)

  

0.468

Bad

163 (13.4)

54 (13.4)

 

 N

260 (21.4)

79 (19.6)

 

Average

618 (50.9)

207 (51.2)

 

 Y

954 (78.6)

325 (80.4)

 

Satisfied

153 (12.6)

49 (12.1)

 

Hypertension (%)

  

0.517

Vomiting (%)

  

0.02

 N

1031 (84.9)

337 (83.4)

 

N

825 (68.0)

300 (74.3)

 

 Y

183 (15.1)

67 (16.6)

 

Y

389 (32.0)

104 (25.7)

 

Diabetes (%)

  

0.231

Abdominal distention (%)

  

0.684

 N

1108 (91.3)

360 (89.1)

 

N

808 (66.6)

274 (67.8)

 

 Y

106 (8.7)

44 (10.9)

 

Y

406 (33.4)

130 (32.2)

 

Smoke (%)

  

0.978

Tachypnea (%)

  

0.352

 N

1025 (84.4)

342 (84.7)

 

N

937 (77.2)

302 (74.8)

 

 Y

189 (15.6)

62 (15.3)

 

Y

277 (22.8)

102 (25.2)

 

Drink (%)

  

0.83

Edema (%)

  

0.599

 N

1112 (91.6)

368 (91.1)

 

N

969 (79.8)

328 (81.2)

 

 Y

102 (8.4)

36 (8.9)

 

Y

245 (20.2)

76 (18.8)

 

Constipation (%)

  

0.731

NRS (%)

  

0.152

 N

690 (56.8)

225 (55.7)

 

0–3

126 (10.4)

55 (13.6)

 

 Y

524 (43.2)

179 (44.3)

 

4–6

664 (54.7)

205 (50.7)

 

Weight loss (%)

  

0.201

7–10

424 (34.9)

144 (35.6)

 

 N

101 (8.3)

25 (6.2)

 

KPS (%)

  

0.313

 Y

1113 (91.7)

379 (93.8)

 

≤30

375 (30.9)

141 (34.9)

 

Insomnia (%)

  

0.062

40

531 (43.7)

169 (41.8)

 

 N

597 (49.2)

221 (54.7)

 

≥50

308 (25.4)

94 (23.3)

 

 Y

617 (50.8)

183 (45.3)

 

QOL (%)

  

0.416

Anorexia (%)

  

0.684

≤30

450 (37.1)

140 (34.7)

 

 N

168 (13.8)

52 (12.9)

 

> 30

764 (62.9)

264 (65.3)

 

 Y

1046 (86.2)

352 (87.1)

 

Status (%)

  

0.655

Nausea (%)

  

0.328

Censored

110 (9.1)

33 (8.2)

 

 N

835 (68.8)

289 (71.5)

 

Dead

1104 (90.9)

371 (91.8)

 

 Y

379 (31.2)

115 (28.5)

    Â